150 related articles for article (PubMed ID: 18711149)
1. Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma.
Lin J; Pu X; Wang W; Matin S; Tannir NM; Wood CG; Wu X
Carcinogenesis; 2008 Nov; 29(11):2112-9. PubMed ID: 18711149
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway.
Margulis V; Lin J; Yang H; Wang W; Wood CG; Wu X
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2366-73. PubMed ID: 18768505
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide excision repair pathway genes and oral premalignant lesions.
Wang Y; Spitz MR; Lee JJ; Huang M; Lippman SM; Wu X
Clin Cancer Res; 2007 Jun; 13(12):3753-8. PubMed ID: 17575242
[TBL] [Abstract][Full Text] [Related]
4. The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma.
Sakano S; Hinoda Y; Okayama N; Kawai Y; Korenaga Y; Eguchi S; Nagao K; Ohmi C; Naito K
Ann Oncol; 2007 Nov; 18(11):1817-27. PubMed ID: 17712032
[TBL] [Abstract][Full Text] [Related]
5. Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Wang Y; Zhang Y; Sun Y; Wu J; Chang J; Xiong Z; Niu F; Gu S; Jin T
Mol Genet Genomic Med; 2019 Nov; 7(11):e966. PubMed ID: 31487124
[TBL] [Abstract][Full Text] [Related]
6. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.
Pan J; Lin J; Izzo JG; Liu Y; Xing J; Huang M; Ajani JA; Wu X
Carcinogenesis; 2009 May; 30(5):785-92. PubMed ID: 19270000
[TBL] [Abstract][Full Text] [Related]
7. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
8. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma.
Xing Q; Li R; Xu A; Qin Z; Tang J; Zhang L; Tang M; Han P; Wang W; Qin C; Du M; Zhang W
Cancer Med; 2019 Jun; 8(6):2886-2896. PubMed ID: 31038847
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in APE1 are associated with renal cell carcinoma risk in a Chinese population.
Cao Q; Qin C; Meng X; Ju X; Ding Q; Wang M; Zhu J; Wang W; Li P; Chen J; Zhang Z; Yin C
Mol Carcinog; 2011 Nov; 50(11):863-70. PubMed ID: 21538578
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk.
Moore LE; Brennan P; Karami S; Menashe I; Berndt SI; Dong LM; Meisner A; Yeager M; Chanock S; Colt J; Schwartz K; Davis F; Zaridze D; Mattveev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Holcatova I; Boffetta P; Chow WH; Rosenberg PS; Rothman N
Cancer Res; 2009 Oct; 69(20):8001-8. PubMed ID: 19808960
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.
van Bemmel DM; Boffetta P; Liao LM; Berndt SI; Menashe I; Yeager M; Chanock S; Karami S; Zaridze D; Matteev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Slamova A; Rothman N; Han SS; Rosenberg PS; Brennan P; Chow WH; Moore LE
PLoS One; 2011; 6(7):e20432. PubMed ID: 21799727
[TBL] [Abstract][Full Text] [Related]
14. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
15. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.
Arjumand W; Ahmad ST; Nafees S; Ali N; Rashid S; Seth A; Sultana S
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma.
Chung CJ; Bao BY; Lin YC; Huang YL; Shiue HS; Ao PL; Pu YS; Huang CY; Hsueh YM
Sci Rep; 2020 Apr; 10(1):6640. PubMed ID: 32313131
[TBL] [Abstract][Full Text] [Related]
17. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Lin YC; Chen WJ; Huang CY; Shiue HS; Pu YS; Chen CH; Su CT
Toxicol Appl Pharmacol; 2017 Oct; 332():1-7. PubMed ID: 28733204
[TBL] [Abstract][Full Text] [Related]
18. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
19. Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.
Rafiq R; Bhat GA; Lone MM; Masood A; Dar NA
Tumour Biol; 2016 Aug; 37(8):10193-207. PubMed ID: 26831662
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]